Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Feb 6, 2016; 7(1): 91-106
Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.91
Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.91
Table 1 Optimal cut-off values for liver stiffness measurement in different etiologies of chronic liver disease
| Optimal cut-off LSM for F2 | Optimal cut-off LSM for F3 | Optimal cut-off for LSM F4 | Ref. | |
| Chronic hepatitis C | 7.6 (5.1-10.1) | 10.9 (8.0-15.4) | 15.3 (11.9-26.5) | [33] |
| Chronic hepatitis B | 7.0 (6.9-7.2) | 8.2 (7.3-9.0) | 11.3 (9.0-13.4) | [33] |
| Alcoholic liver disease | 8.9 (2.8-46.4) | 10.3 (7.7-20.8) | 18.4 (12.2-75.0) | [66] |
| Non-alcoholic fatty liver disease | 7.0 (6.7-7.8) | 8.7 (7.1-10.4) | 10.3 (10.3-22.3) | [35-37] |
| Cholestatic liver disease | 7.3 | 9.8 | 17.3 | [54] |
- Citation: Chang PE, Goh GBB, Ngu JH, Tan HK, Tan CK. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 91-106
- URL: https://www.wjgnet.com/2150-5349/full/v7/i1/91.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i1.91